查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2098890

人工心臟瓣膜市場－2026-2032年全球市場預測

Prosthetic Heart Valves Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工心臟瓣膜市場將成長至 277.6 億美元，複合年成長率為 11.91%。

主要市場統計數據
基準年 2025 126.2億美元
預計年份：2026年 141.9億美元
預測年份 2032 277.6億美元
複合年成長率 (%) 11.91%

人工心臟瓣膜在治療嚴重瓣膜性心臟病方面發揮核心作用，這些疾病包括主動脈瓣狹窄、二尖瓣逆流、三尖瓣逆流以及由風濕性、退化性、先天性和感染性等病因引起的瓣膜功能障礙。全球心血管疾病發生率的上升、人口老化、診斷手段的改進以及置換術和經導管瓣膜置換術術的普及，都推動了人工心臟瓣膜的需求成長。此領域涵蓋機械瓣膜、生物瓣膜、經導管主動脈瓣置換裝置、經導管二尖瓣和三尖瓣瓣環成形術系統以及新一代聚合物和組織工程瓣膜概念。在臨床決策中，瓣膜的耐久性、血流動力學性能、血栓形成、抗凝血治療需求、患者的解剖特徵、瓣膜的終身管理以及再次手術的適用性等因素正日益受到重視。隨著治療途徑轉向早期診斷和微創干預，人工心臟瓣膜領域正變得更加多學科交叉，循環系統、心臟外科、診斷成像、介入性循環系統、麻醉學、復健和術後監測等學科相互協作，整合為一個協調的瓣膜護理體系。

正在重塑人工心臟瓣膜照護的變革性變化。

人工心臟瓣膜產業正經歷結構性變革，其驅動力包括經導管技術、終身疾病管理和個人化治療方案。經導管主動脈瓣置換術的應用範圍正從最初僅限於非手術病例和高手術風險患者，擴展到基於隨機試驗證據和最新指南建議的更廣泛的臨床實踐。同時，經導管二尖瓣和三尖瓣修復與置換術仍在繼續應對與主動脈瓣相比標準化程度較低的複雜解剖結構。由於無需終身抗凝血治療，生物瓣膜在許多老年患者中逐漸成為臨床首選，而機械瓣膜對於某些優先考慮長期耐用性且能夠安全管理抗凝血治療的年輕患者而言仍然是重要的選擇。另一個顯著的變化是心臟超音波圖、電腦斷層掃描 (CT)、磁振造影(MRI) 和融合成像）在瓣膜尺寸選擇、入路規劃、手術指導和併發症減少方面發揮越來越重要的作用。此外，醫院正在採用「心臟團隊」模式，使患者選擇與實證指南、手術風險評分、虛弱程度評估、解剖結構匹配以及長期再次干預策略一致。這些變革將關注點從單一器械的表現轉向整合式瓣膜治療方案，從而最佳化診斷、干預、追蹤和預後。

人工智慧對人工心臟瓣膜的累積影響

人工智慧在整個人工心臟瓣膜生態系統中發揮著日益重要的作用，它能夠提高診斷準確性、最佳化手術規劃、提升工作流程效率並改善術後後續觀察。在心臟超音波圖和心臟CT中，人工智慧驅動的影像分析可以輔助進行瓣膜解剖評估、鈣化特徵分析、瓣環測量、左心室功能評估，並識別可能需要轉診至專業瓣膜團隊的患者。在介入治療規劃中，機器學習模型正被用於預測瓣週漏、傳導障礙、血管併發症、瓣膜與患者不匹配、瓣膜血栓症以及經導管術後是否需要植入心律調節器。人工智慧還能透過幫助確定嚴重瓣膜疾病病例的優先順序、簡化影像診斷流程以及減少影響瓣膜尺寸測量的變異性來支持臨床實踐。在製造和研究領域，計算建模、數位孿生和人工智慧驅動的設計可以加速在臨床應用前對瓣膜應力、動態、耐久性風險和血栓形成潛能的評估。然而，人工智慧的實施需要透明的檢驗、多樣化的訓練資料集、監管部門的批准、網路安全措施、臨床醫生的監督，以及與現有影像和電子健康記錄記錄系統的整合。因此，人工智慧的累積影響遠不止於自動化；它還有助於創建更個人化、循證且可複製的人工瓣膜護理路徑。

全球人工心臟瓣膜部署的關鍵區域性見解

在亞太地區，人工心臟瓣膜手術數量的成長主要受人口大規模化、人們對退化性瓣膜性心臟病的認知不斷提高、多個中低收入國家風濕性心臟疾病負擔沉重以及中國、印度、日本、韓國、澳大利亞和東南亞等地三級心臟醫療基礎設施擴建等因素驅動。北美地區的特點是經導管瓣膜治療普及率高、擁有完善的、以指南為基礎的心臟醫療團隊、保險報銷體系完善，以及能夠廣泛獲得先進的心臟影像影像和結構性心臟病診療服務，尤其是在主動脈瓣置換術和複雜二尖瓣介入治療方面。在拉丁美洲，主要都市區的手術能力正在提升，巴西和墨西哥發揮著重要作用，但公立和私立醫療系統之間在醫療資源取得方面的差距仍然影響著及時診斷和先進的瓣膜介入治療。歐洲擁有許多優勢，例如成熟的心臟外科手術網路、結構性心臟疾病方面的高水平專業知識、完善的臨床註冊系統以及廣泛採用循證瓣膜治療指南。西歐的醫療服務取得途徑通常優於東歐部分地區。在中東，尤其是在海灣國家，政府正增加對先進心血管中心、醫療旅遊和專科醫生培訓的投資。同時，非洲面臨風濕性和退化性瓣膜性心臟病的雙重負擔，在篩檢、手術能力、導管介入治療的可及性以及長期抗凝血治療監測方面仍然存在差距。在所有地區，最重要的差異因素不僅在於醫療設備的可近性，還在於轉診途徑、影像檢查能力、多專業專家團隊、報銷模式以及人工瓣膜後續觀察的追蹤系統。

影響人工心臟瓣膜取得的關鍵群體特定見解

在東南亞國協，人工心臟瓣膜的發展趨勢正在呈現多元化。新加坡、泰國和馬來西亞在先進的結構性心臟病治療方面擁有相對較好的資源，而印尼、越南和菲律賓等人口大國則在經濟負擔、轉診系統和勞動力短缺等限制因素的限制下，正努力擴大其心臟醫療保健基礎設施。海灣合作理事會（GCC）國家的特點是：對三級醫療投入巨大，心血管疾病風險因素不斷增加，以及在專業中心和公共醫療資金的支持下，微創瓣膜治療得到廣泛應用。歐盟的優勢在於：醫療設備法規的統一性、跨境臨床合作以及強大的學術心臟中心基礎。同時，對上市後監測和真實世界數據的持續重視正在影響醫療設備的評估和臨床實踐。金磚國家擁有龐大的患者群體，其國內醫療保健系統正在不斷擴展，但在瓣膜性心臟病的診斷和治療方面仍存在巨大的未滿足需求。在風濕性疾病、就醫延誤和專科醫生分佈不均等問題依然嚴峻的地區，這一趨勢尤其顯著。七國集團（G7）國家通常擁有先進的保險報銷體系、高水準的手術技術以及完善的註冊登記系統，支持機械瓣膜、生物瓣膜和經導管心臟瓣膜的循證應用。北約成員國（其中許多與歐洲和北美先進的醫療保健體系重疊）在心臟護理方面擁有強大的機構能力；然而，由於各國報銷政策、醫院分佈和專科醫生數量等因素，醫療服務的可及性仍然存在差異。這些群體層面的趨勢表明，人工心臟瓣膜的採用受到經濟實力、監管成熟度、培訓計畫、疾病流行病學以及終身移植後監測能力的影響。

人工心臟瓣膜治療的關鍵國家概況

美國憑藉其完善的結構性心臟疾病項目、臨床指南的採納以及先進影像技術的廣泛應用，在經導管和外科心臟瓣膜置換術的創新方面保持主導地位。加拿大則強調公共資金支持的醫療服務、卓越的區域醫療中心以及對高度複雜手術的謹慎優先排序。墨西哥正在主要城市擴大瓣膜治療能力，但公立和私立醫療機構在醫療服務取得方面仍存在顯著差異。巴西擁有大型轉診醫院的支持，是拉丁美洲心臟外科和介入性心臟病學生態系統最發達的國家之一，但不同地區的醫療服務取得情況有所不同。英國的優勢在於其國家指南框架和專業的心臟瓣膜服務，而德國則擁有強大的心臟外科基礎和先進的技術。法國將先進的介入治療能力與結構化的報銷機制相結合，義大利和西班牙則擁有由經驗豐富的心臟中心支持的成熟瓣膜計畫。在俄羅斯，主要大都市地區的心血管醫療基礎設施正在不斷完善，但不同地區的醫療服務取得也存在差異。在中國，透過醫院擴建、醫生培訓、國內臨床研究以及擴大鈣化性和風濕性瓣膜性心臟病的診斷範圍，結構性心臟疾病的醫療體係正在迅速加強。在印度，風濕性和退化性瓣膜性心臟病較為複雜，雖然大型醫院能夠進行先進的手術，但費用、診斷延遲和醫療資源分配不均仍是主要挑戰。日本人口老化嚴重，微創手術已廣泛應用於合格的患者。同時，在澳大利亞，以指南為基礎的醫療模式與遍布各大都市地區的專業瓣膜中心相結合。韓國的手術技術水準高超，醫院基礎建設先進，影像導引下的結構性心臟介入治療應用日益廣泛。在這些國家，人工心臟瓣膜的使用受到流行病學、臨床證據、醫保報銷、醫院集中度、專科醫師訓練和長期追蹤體係等因素的影響。

為人工心臟瓣膜行業的領導者提供的實用建議

產業領導者應優先考慮以實證醫學為基礎的創新，以提高外科和經導管心臟瓣膜的耐用性、血流動力學性能、植入便利性和病人安全性。產品策略應著眼於瓣膜的終身管理，包括瓣中瓣可行性、降低血栓形成風險、最大限度減少瓣週漏、降低心律調節器風險、改善冠狀動脈通路以及與先進影像工作流程的兼容性。各機構應投資於醫生教育、導師培訓、模擬訓練以及多學科心臟團隊的支持，尤其是在經導管瓣膜置換計畫正在擴展的地區。擴大瓣膜覆蓋範圍還需要透過與醫院和醫療保健系統合作，加強主動脈瓣狹窄、二尖瓣逆流、三尖瓣逆流和風濕性瓣膜疾病的篩檢，因為診斷延遲仍然是實現最佳治療效果的一大障礙。監管機構和臨床團隊應加強真實世界數據（REW）的收集、註冊登記、上市後監測以及耐用性和安全性結果的透明報告。領導者也應制定人工智慧賦能的資料策略，以支援影像分析、手術規劃、品質改善和遠端監測，同時保障隱私、互通性和臨床課責。最後，新興市場的策略不應依賴僅適用於資源豐富的心臟中心的模式，而應根據當地的經濟能力、培訓、基礎設施和後續追蹤的實際情況進行調整。

獲取有關人工心臟瓣膜的實證知識的調查方法

本執行摘要基於系統性的二手研究方法，採用經驗證的公開資料，包括臨床實踐指南、同行評審的循環系統和心臟外科文獻、監管出版刊物、公共衛生數據、醫學會聲明、疾病負擔數據以及臨床註冊登記資訊來源（如有）。研究途徑調查方法強調跨獨立資訊來源進行檢驗，以檢驗有關瓣膜性心臟病流行病學趨勢、外科和經導管治療路徑、區域醫療資源獲取差異、技術採納促進因素以及臨床結果等方面的考慮。本分析不涉及市場規模、市場佔有率和預測，而是專注於定性和循證的行業趨勢。關鍵主題的檢驗涵蓋臨床相關性、監管成熟度、醫療基礎設施、報銷環境、疾病負擔、醫療專業人員能力以及結構化心臟疾病計畫的實施。區域、群體和國家層面的見解是根據醫療保健系統的狀況、專家的可用性、診斷的可及性、法律規範以及植入後護理的連續性來解讀的，並注意確保結論反映已建立和新興醫療保健環境的實際情況。

結論：人工心臟瓣膜治療的未來

人工心臟瓣膜領域正從以手術為中心的治療模式轉向以技術驅動的瓣膜性心臟病綜合管理模式。雖然外科瓣膜置換術仍然必不可少，但經導管治療正在為老年患者、高風險患者或適合微創手術的解剖結構異常患者拓展治療選擇。心臟醫療團隊基於實證醫學的決策、先進的影像技術、人工智慧驅動的分析、真實世界結果追蹤以及強化的術後監測，對於安全有效地實施這些治療至關重要。區域差異依然顯著，尤其是在風濕性疾病負擔沉重、診斷基礎設施不足、經濟限制以及專科醫生短缺等因素導致治療延誤的地區。能夠將創新與臨床證據、終身患者護理、公平獲取以及當地醫療系統需求相結合的行業領導者，將更有能力支持人工心臟瓣膜治療效果的提升。該領域未來的發展將由更耐用的醫療設備、更聰明的治療計劃、更廣泛的篩檢以及整合的護理路徑所塑造，從而確保在合適的時間為合適的患者提供合適的瓣膜治療。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 人工心臟瓣膜市場：依瓣膜類型分類

  • 機械的
    • 二尖瓣
    • 球形籠
    • 傾斜盤
  • 組織
    • 牛
    • 同種異體移植
    • 豬

第8章：人工心臟瓣膜市場：依材料類型分類

  • 金屬閥門
  • 生物基瓣膜
  • 聚合物閥門

第9章：人工心臟瓣膜市場：依手術方式分類

  • 手術置換術
    • 微創
    • 傳統胸骨切開術
  • 經導管瓣膜置換術
    • 經心尖導管插入術
    • 經股動脈

第10章：人工心臟瓣膜市場：依應用領域分類

  • 主動脈瓣
  • 二尖瓣
  • 三尖瓣

第11章 人工心臟瓣膜市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第12章 人工心臟瓣膜市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：人工心臟瓣膜市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 人工心臟瓣膜市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • AorTx Incorporated
  • Artivion Incorporated
  • Biotronik SE and Company KG
  • Boston Scientific Corporation
  • Braile Biomedica Industria e Comercio SA
  • Carvolix SA
  • Colibri Heart Valve LLC
  • Comed BV
  • Edwards Lifesciences Corporation
  • Foldax Incorporated
  • Heart Leaflet Technologies Incorporated
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltda
  • Lepu Medical Technology Beijing Company Limited
  • LivaNova Public Limited Company
  • Medtronic Public Limited Company
  • Meril Life Sciences Private Limited
  • Micro Interventional Devices Incorporated
  • MicroPort Scientific Corporation
  • NaviGate Cardiac Structures Incorporated
  • Peijia Medical Device Company Limited
  • Symetis SA
  • Teleflex Incorporated
  • Terumo Corporation
  • Transcatheter Technologies GmbH
  • TTK Healthcare Limited
  • ValveXchange Incorporated
  • Venus Medtech Hangzhou Incorporated
  • Xeltis BV
Product Code: MRR-62667ADFA787

The Prosthetic Heart Valves Market is projected to grow by USD 27.76 billion at a CAGR of 11.91% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.62 billion
Estimated Year [2026] USD 14.19 billion
Forecast Year [2032] USD 27.76 billion
CAGR (%) 11.91%

Prosthetic heart valves are central to the treatment of severe valvular heart disease, including aortic stenosis, mitral regurgitation, tricuspid regurgitation, and valve dysfunction associated with rheumatic, degenerative, congenital, and infective etiologies. Demand is being shaped by the global rise in cardiovascular disease, population aging, improved diagnostic access, and expanding use of surgical valve replacement and transcatheter valve replacement techniques. The field spans mechanical valves, bioprosthetic valves, transcatheter aortic valve replacement devices, transcatheter mitral and tricuspid solutions, annuloplasty systems, and next-generation polymeric and tissue-engineered valve concepts. Clinical decision-making increasingly emphasizes durability, hemodynamic performance, thrombogenicity, anticoagulation requirements, patient anatomy, lifetime valve management, and suitability for redo procedures. As care pathways shift toward earlier diagnosis and less invasive interventions, the prosthetic heart valves landscape is becoming more multidisciplinary, connecting cardiology, cardiac surgery, imaging, interventional cardiology, anesthesiology, rehabilitation, and post-procedural monitoring into a coordinated valve-care continuum.

Transformative Shifts Reshaping Prosthetic Heart Valve Care

The prosthetic heart valves industry is undergoing a structural transformation driven by transcatheter technologies, lifetime disease management, and patient-specific treatment planning. Transcatheter aortic valve implantation has moved from use in inoperable and high-risk surgical candidates into broader clinical practice following randomized trial evidence and updated guideline recommendations, while transcatheter mitral and tricuspid valve repair and replacement continue to address complex anatomies that are less standardized than the aortic position. Bioprosthetic valves are gaining clinical preference in many older patients because they reduce the need for lifelong anticoagulation, whereas mechanical heart valves continue to be relevant for selected younger patients who prioritize long-term durability and can manage anticoagulation safely. Another major shift is the growing role of advanced imaging, including echocardiography, computed tomography, cardiac magnetic resonance, and fusion imaging, in valve sizing, access planning, procedural guidance, and complication reduction. Hospitals are also adopting heart-team models to align patient selection with evidence-based guidelines, procedural risk scores, frailty assessment, anatomical suitability, and long-term reintervention strategies. These shifts are expanding the emphasis from single-device performance to integrated valve programs that optimize diagnosis, intervention, follow-up, and outcomes.

Cumulative Impact of Artificial Intelligence on Prosthetic Heart Valves

Artificial intelligence is becoming increasingly relevant across the prosthetic heart valves ecosystem by improving diagnostic precision, procedural planning, workflow efficiency, and post-treatment surveillance. In echocardiography and cardiac computed tomography, AI-enabled image analysis can support valve anatomy assessment, calcification characterization, annular measurement, left ventricular function evaluation, and identification of patients who may benefit from referral to specialized valve teams. In interventional planning, machine learning models are being evaluated to predict paravalvular leak, conduction disturbances, vascular complications, prosthesis-patient mismatch, leaflet thrombosis, and need for pacemaker implantation after transcatheter procedures. AI also supports clinical operations by helping prioritize severe valvular disease cases, streamline imaging interpretation, and reduce variability in measurements that influence prosthetic valve sizing. In manufacturing and research, computational modeling, digital twins, and AI-assisted design can accelerate evaluation of leaflet stress, flow dynamics, durability risks, and thrombosis potential before clinical deployment. However, adoption depends on transparent validation, diverse training datasets, regulatory acceptance, cybersecurity controls, clinician oversight, and integration with existing imaging and electronic health record systems. The cumulative impact of AI is therefore not simply automation; it is the creation of more personalized, evidence-aligned, and reproducible prosthetic valve care pathways.

Key Regional Insights Across Global Prosthetic Heart Valve Adoption

In Asia-Pacific, growth in prosthetic heart valve procedures is supported by large aging populations, increasing recognition of degenerative valve disease, substantial rheumatic heart disease burden in several low- and middle-income settings, and expanding tertiary cardiac-care infrastructure in China, India, Japan, South Korea, Australia, and Southeast Asia. North America is characterized by high adoption of transcatheter valve therapies, robust guideline-driven heart-team pathways, strong reimbursement infrastructure, and widespread access to advanced cardiac imaging and structural heart programs, particularly for aortic valve replacement and complex mitral valve intervention. Latin America shows rising procedural capability in major urban centers, with Brazil and Mexico playing important roles, while access differences between public and private health systems continue to influence timely diagnosis and advanced valve intervention. Europe benefits from mature cardiac surgery networks, strong structural heart expertise, established clinical registries, and broad adoption of evidence-based valve guidelines, with Western Europe generally demonstrating greater procedural access than parts of Eastern Europe. The Middle East is investing in advanced cardiovascular centers, medical tourism, and specialist training, particularly in Gulf countries, while Africa faces a dual burden of rheumatic and degenerative valve disease with persistent gaps in screening, surgical capacity, catheter-based intervention availability, and long-term anticoagulation monitoring. Across all regions, the most important differentiators are not only device availability but also referral pathways, imaging capacity, multidisciplinary expertise, reimbursement models, and follow-up systems for prosthetic valve surveillance.

Key Group Insights Influencing Prosthetic Heart Valve Access

ASEAN countries present diverse prosthetic heart valve dynamics, with Singapore, Thailand, and Malaysia showing stronger access to advanced structural heart procedures, while larger populations in Indonesia, Vietnam, and the Philippines continue to expand cardiac-care infrastructure amid affordability, referral, and workforce constraints. The GCC is distinguished by significant investment in tertiary hospitals, rising cardiovascular risk factors, and growing adoption of minimally invasive valve interventions supported by specialist centers and public health funding. The European Union benefits from harmonized medical device regulation, cross-border clinical collaboration, and a strong base of academic cardiac centers, while ongoing emphasis on post-market surveillance and real-world evidence is shaping device evaluation and clinical practice. BRICS countries combine large patient populations, expanding domestic healthcare capacity, and substantial unmet need for valve disease diagnosis and treatment, particularly where rheumatic disease, late presentation, and uneven specialist distribution remain important clinical challenges. G7 countries generally have advanced reimbursement systems, high procedural expertise, and established registries that support evidence-based use of mechanical, bioprosthetic, and transcatheter heart valves. NATO member countries, many of which overlap with advanced European and North American health systems, show strong institutional capacity for cardiac care, but access still varies based on national reimbursement policies, hospital distribution, and specialist workforce availability. These group-level patterns show that prosthetic heart valve adoption is influenced by economic capacity, regulatory maturity, training systems, disease epidemiology, and the ability to sustain lifelong monitoring after implantation.

Key Country Insights in Prosthetic Heart Valve Care

The United States remains a leading environment for transcatheter and surgical prosthetic heart valve innovation due to extensive structural heart programs, clinical guideline adoption, and broad use of advanced imaging, while Canada emphasizes publicly funded access, regional centers of excellence, and careful prioritization of high-complexity procedures. Mexico is expanding valve intervention capacity in major cities, though public-private access differences remain significant. Brazil has one of Latin America's most developed cardiac surgery and interventional cardiology ecosystems, supported by major referral hospitals, while broader access varies across regions. The United Kingdom benefits from national guideline frameworks and specialist heart valve services, Germany has a strong cardiac surgery base and high procedural sophistication, France combines advanced interventional capability with structured reimbursement pathways, and Italy and Spain maintain established valve programs supported by experienced cardiac centers. Russia has expanded cardiovascular infrastructure in major urban areas, but access can vary geographically. China is rapidly strengthening structural heart capacity through hospital expansion, physician training, domestic clinical research, and wider diagnosis of calcific and rheumatic valve disease. India faces a substantial mix of rheumatic and degenerative valve disease, with leading hospitals offering advanced procedures while affordability, late diagnosis, and uneven access remain central challenges. Japan has a highly aging population and strong adoption of minimally invasive approaches for suitable patients, while Australia combines guideline-based care with specialized valve centers across major metropolitan regions. South Korea shows strong procedural expertise, advanced hospital infrastructure, and increasing use of imaging-guided structural heart interventions. Across these countries, prosthetic heart valve utilization is shaped by epidemiology, clinical evidence, reimbursement, hospital concentration, specialist training, and long-term follow-up capacity.

Actionable Recommendations for Prosthetic Heart Valve Industry Leaders

Industry leaders should prioritize evidence-based innovation that improves durability, hemodynamic performance, deliverability, and patient safety across surgical and transcatheter prosthetic heart valves. Product strategies should address lifetime valve management, including valve-in-valve feasibility, reduced thrombogenicity, minimized paravalvular leak, lower pacemaker risk, improved coronary access, and compatibility with advanced imaging workflows. Organizations should invest in physician education, proctoring, simulation-based training, and multidisciplinary heart-team support, particularly in regions where transcatheter valve programs are scaling. Expanding access also requires partnerships with hospitals and health systems to improve screening for aortic stenosis, mitral regurgitation, tricuspid regurgitation, and rheumatic valve disease, because delayed diagnosis remains a major barrier to optimal outcomes. Regulatory and clinical teams should strengthen real-world evidence generation, registry participation, post-market surveillance, and transparent reporting of durability and safety outcomes. Leaders should also build AI-ready data strategies that support imaging analytics, procedural planning, quality improvement, and remote monitoring while maintaining privacy, interoperability, and clinical accountability. Finally, emerging-market strategies should adapt to local affordability, training, infrastructure, and follow-up realities rather than relying on models designed only for high-resource cardiac centers.

Research Methodology for Evidence-Based Prosthetic Valve Insights

This executive summary is developed through a structured secondary-research approach using verified and publicly available sources, including clinical practice guidelines, peer-reviewed cardiology and cardiac surgery literature, regulatory publications, public health data, medical society statements, disease burden resources, and evidence from clinical registries where available. The methodology emphasizes triangulation across independent sources to validate trends in valve disease epidemiology, surgical and transcatheter treatment pathways, regional access differences, technology adoption drivers, and clinical outcome considerations. The analysis excludes market sizing, market share, and forecasting, focusing instead on qualitative and evidence-backed industry dynamics. Key themes are assessed through clinical relevance, regulatory maturity, healthcare infrastructure, reimbursement context, disease burden, workforce capacity, and adoption of structural heart programs. Regional, group, and country insights are interpreted through the lens of healthcare system readiness, specialist availability, diagnostic access, regulatory pathways, and continuity of post-implantation care, ensuring that conclusions reflect practical realities across both advanced and emerging healthcare settings.

Conclusion: The Future of Prosthetic Heart Valve Care

The prosthetic heart valves landscape is evolving from procedure-centered treatment toward comprehensive, technology-enabled valve disease management. Surgical valve replacement remains essential, while transcatheter solutions are expanding treatment options for patients who are older, higher risk, or anatomically suited to minimally invasive intervention. Evidence-based heart-team decision-making, advanced imaging, AI-enabled analytics, real-world outcome tracking, and stronger post-procedure surveillance are becoming critical to safe and effective adoption. Regional disparities remain substantial, particularly where rheumatic disease burden, limited diagnostic infrastructure, affordability constraints, and specialist shortages delay treatment. Industry leaders that align innovation with clinical evidence, lifetime patient management, equitable access, and local health-system needs will be best positioned to support improved outcomes in prosthetic heart valve care. The future of this field will be defined by durable devices, smarter planning, broader screening, and integrated care pathways that deliver the right valve therapy to the right patient at the right time.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Prosthetic Heart Valves Market, by Valve Type

  • 7.1. Introduction
  • 7.2. Mechanical
    • 7.2.1. Bileaflet
    • 7.2.2. Caged Ball
    • 7.2.3. Tilting Disc
  • 7.3. Tissue
    • 7.3.1. Bovine
    • 7.3.2. Homograft
    • 7.3.3. Porcine

8. Prosthetic Heart Valves Market, by Material Type

  • 8.1. Introduction
  • 8.2. Metal Based Valves
  • 8.3. Tissue Based Valves
  • 8.4. Polymer Based Valves

9. Prosthetic Heart Valves Market, by Procedure

  • 9.1. Introduction
  • 9.2. Surgical Replacement
    • 9.2.1. Minimally Invasive
    • 9.2.2. Traditional Sternotomy
  • 9.3. Transcatheter Valve Replacement
    • 9.3.1. Transapical
    • 9.3.2. Transfemoral

10. Prosthetic Heart Valves Market, by Application

  • 10.1. Introduction
  • 10.2. Aortic
  • 10.3. Mitral
  • 10.4. Tricuspid

11. Prosthetic Heart Valves Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals

12. Prosthetic Heart Valves Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Prosthetic Heart Valves Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Prosthetic Heart Valves Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. AorTx Incorporated
  • 16.3. Artivion Incorporated
  • 16.4. Biotronik SE and Company KG
  • 16.5. Boston Scientific Corporation
  • 16.6. Braile Biomedica Industria e Comercio S.A.
  • 16.7. Carvolix SA
  • 16.8. Colibri Heart Valve LLC
  • 16.9. Comed BV
  • 16.10. Edwards Lifesciences Corporation
  • 16.11. Foldax Incorporated
  • 16.12. Heart Leaflet Technologies Incorporated
  • 16.13. JenaValve Technology GmbH
  • 16.14. Labcor Laboratorios Ltda
  • 16.15. Lepu Medical Technology Beijing Company Limited
  • 16.16. LivaNova Public Limited Company
  • 16.17. Medtronic Public Limited Company
  • 16.18. Meril Life Sciences Private Limited
  • 16.19. Micro Interventional Devices Incorporated
  • 16.20. MicroPort Scientific Corporation
  • 16.21. NaviGate Cardiac Structures Incorporated
  • 16.22. Peijia Medical Device Company Limited
  • 16.23. Symetis SA
  • 16.24. Teleflex Incorporated
  • 16.25. Terumo Corporation
  • 16.26. Transcatheter Technologies GmbH
  • 16.27. TTK Healthcare Limited
  • 16.28. ValveXchange Incorporated
  • 16.29. Venus Medtech Hangzhou Incorporated
  • 16.30. Xeltis BV

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROSTHETIC HEART VALVES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PROSTHETIC HEART VALVES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PROSTHETIC HEART VALVES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PROSTHETIC HEART VALVES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PROSTHETIC HEART VALVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL PROSTHETIC HEART VALVES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL PROSTHETIC HEART VALVES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MECHANICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MECHANICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MECHANICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BILEAFLET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BILEAFLET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BILEAFLET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAGED BALL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAGED BALL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAGED BALL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TILTING DISC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TILTING DISC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TILTING DISC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BOVINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BOVINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BOVINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOMOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOMOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOMOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PORCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PORCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PORCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL METAL BASED VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL METAL BASED VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL METAL BASED VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TISSUE BASED VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TISSUE BASED VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TISSUE BASED VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYMER BASED VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYMER BASED VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POLYMER BASED VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRADITIONAL STERNOTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TRADITIONAL STERNOTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRADITIONAL STERNOTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TRANSCATHETER VALVE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSCATHETER VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TRANSCATHETER VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSAPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSAPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSAPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSFEMORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSFEMORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSFEMORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AORTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AORTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AORTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MITRAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MITRAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MITRAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TRICUSPID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TRICUSPID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TRICUSPID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 153. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 179. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 182. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 183. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 184. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. G7 PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 189. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 190. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 193. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 194. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL PROSTHETIC HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. CANADA PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 210. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 211. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 215. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. CANADA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 220. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 221. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 224. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 225. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. MEXICO PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. BRAZIL PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 261. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 270. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 271. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 273. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 274. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 275. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. RUSSIA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. ITALY PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 280. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. ITALY PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 290. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 291. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 293. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 294. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 295. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. SPAIN PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. INDIA PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 310. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 311. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 313. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 314. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 315. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. INDIA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 320. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 321. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 323. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 324. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 325. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 326. JAPAN PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 327. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 328. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 330. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 334. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 336. AUSTRALIA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 337. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY VALVE TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY MECHANICAL, 2018-2032 (USD MILLION)
  • TABLE 340. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY TISSUE, 2018-2032 (USD MILLION)
  • TABLE 341. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 343. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 344. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 345. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 346. SOUTH KOREA PROSTHETIC HEART VALVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 347. GLOBAL PROSTHETIC HEART VALVES MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 348. GLOBAL PROSTHETIC HEART VALVES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025